Inquiry Basket
2'-Modified Nucleosides
(288/288) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(236/236) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(134/134) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
(288/288) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(236/236) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(134/134) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All
1-(b-D-Xylofuranosyl)uracil
Description: 1-(b-D-Xylofuranosyl)uracil, a potent nucleoside analogue, has proven efficacy in treating herpes simplex virus infections as an antiviral agent. Its active mechanism, closely resembling that of natural nucleosides, gives it the ability to impair viral replication, making it a promising therapeutic option for herpes simplex infections.
CAT: BRP-01776
CAS: 16535-78-7
MF: C9H12N2O6
MF: 244.20
Purity: ≥95%
Appearance: White or off-white solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $198 | In stock |
Storage: Store at -20°C
Density: 1.674±0.06 g/cm3 (Predicted)
Melting Point: 158-158.5°C
InChIKey: DRTQHJPVMGBUCF-PXBUCIJWSA-N
Solubility: Soluble in Ethanol
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6+,7-,8-/m1/s1
Synonyms: Xylo-uridine; 1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-(beta-D-Xylofuranosyl)uracil; 2,4(1H,3H)-Pyrimidinedione, 1-β-D-xylofuranosyl-; 9-(β-D-Xylofuranosyl)uracil; 1-β-D-Xylofuranosyl-2,4(1H,3H)-pyrimidinedione; 1-Xylosyluracil; 1-β-D-Xylofuranosyluracil; 1-β-D-Xylosyluracil; β-D-Xylouracil
Binodenoson
Description: Binodenoson is a pharmacologic stress agent specific to the only adenosine receptor necessary for increased cardiac blood flow, the A2A receptor agonist. It is used to diagnose coronary artery disease.
CAT: BRP-01783
CAS: 144348-08-3
MF: C17H25N7O4
MF: 391.42
Purity: 95%
Appearance: White solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 10 mg | $398 | In stock |
Storage: Store at -20 °C
Density: 1.76±0.1 g/cm3
Melting Point: 154-157°C
Boiling Point: 765.6±70.0 °C at 760 mmHg
Application: Purinergic P1 Receptor Agonists
InChIKey: XJFMHMFFBSOEPR-XNIJJKJLSA-N
Solubility: Soluble in DMSO: 125 mg/mL
CanonicalSMILES: C1CCC(CC1)C=NNC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N
IUPAC Name: (2R,3R,4S,5R)-2-[6-amino-2-[2-(cyclohexylmethylidene)hydrazinyl]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C17H25N7O4/c18-14-11-15(22-17(21-14)23-20-6-9-4-2-1-3-5-9)24(8-19-11)16-13(27)12(26)10(7-25)28-16/h6,8-10,12-13,16,25-27H,1-5,7H2,(H3,18,21,22,23)/t10-,12-,13-,16-/m1/s1
Synonyms: MRE0470; MRE-0470; WRC-0470; SHA-174; 2-((Cyclohexylmethylene)hydrazino)adenosine; 2-(Cyclohexylmethylidene hydrazino) adenosine; 2-[2-(Cyclohexylmethylene)hydrazinyl]adenosine; 2-(Cyclohexylmethylidenehydrazino)adenosine; SHA 211; WRC 0470
5-Hydroxyuridine
Description: 5-Hydroxyuridine is an anticancer agent. 5-Hydroxyuridine is a modified nucleoside derived from uridine, commonly found in RNA molecules, especially in transfer RNA (tRNA), where it plays a significant role in RNA structure and function.
CAT: BRP-01788
CAS: 957-77-7
MF: C9H12N2O7
MF: 260.20
Purity: ≥95%
Appearance: White to Off-White Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 1 g | $998 | In stock |
Storage: Store at -20°C under inert atmosphere
Density: 1.848±0.1 g/cm3
Melting Point: >240°C (dec.)
Symbol: ho5U
InChIKey: QXDXBKZJFLRLCM-UAKXSSHOSA-N
Solubility: Soluble in Water (Slightly, Heated, Sonicated)
CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxypyrimidine-2,4-dione
InChI: InChI=1S/C9H12N2O7/c12-2-4-5(14)6(15)8(18-4)11-1-3(13)7(16)10-9(11)17/h1,4-6,8,12-15H,2H2,(H,10,16,17)/t4-,5-,6-,8-/m1/s1
Synonyms: Uridine, 5-hydroxy-; 1-(beta-D-ribofuranosyl)-5-hydroxypyrimidine-2,4(1H,3H)-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-hydroxy-pyrimidine-2,4-dione; 1-β-D-Ribofuranosylisobarbituric acid; Isobarbituridine
N6,2'-O-dimethyladenosine
Description: N6,2'-O-dimethyladenosine is a naturally occurring modified nucleoside in RNA. It is known to play roles in regulating RNA stability, translation, and other cellular processes.
CAT: BRP-01795
CAS: 57817-83-1
MF: C12H17N5O4
MF: 295.29
Purity: ≥95%
Appearance: White to Off-white Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 50 mg | $469 | In stock |
Storage: Store at -20°C under inert atmosphere
Density: 1.7±0.1 g/cm3
Melting Point: 177-179°C
Boiling Point: 606.5±65.0°C at 760 mmHg
Symbol: m6Am
InChIKey: GRYSXUXXBDSYRT-WOUKDFQISA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Sonicated)
CanonicalSMILES: CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC
IUPAC Name: (2R,3R,4R,5R)-2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-ol
InChI: InChI=1S/C12H17N5O4/c1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(20-2)8(19)6(3-18)21-12/h4-6,8-9,12,18-19H,3H2,1-2H3,(H,13,14,15)/t6-,8-,9-,12-/m1/s1
Synonyms: N6-Methyl-2'-O-methyladenosine; Adenosine, N-methyl-2'-O-methyl-; N(6),O(2')-Dimethyladenosine; N-Methyl-2'-O-methyladenosine; 2'-O-Methyl-6-methyladenosine; 6-Methyl-2'-O-methyladenosine; N6,O2'-Dimethyladenosine; Sulodexide
4-Thiouridine
Description: Nucleotide analogue is essential to cell growth in certain bacterial species, which is also able to chelate with certain metal ions, and in tRNA. It can act as a built-in antiphotomutagenic agent protecting Escherichia coli cells against mutagenesis.
CAT: BRP-01799
CAS: 13957-31-8
MF: C9H12N2O5S
MF: 260.27
Purity: ≥95%
Appearance: Light Yellow to Yellow Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 1 g | $298 | In stock |
Storage: Store at 2-8°C
Density: 1.72 g/cm3
Melting Point: 80-83°C; 139-140°C (ethanol)
Application: Affinity Labels
Symbol: s4U
InChIKey: ZLOIGESWDJYCTF-XVFCMESISA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Sonicated)
CanonicalSMILES: C1=CN(C(=O)NC1=S)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidenepyrimidin-2-one
InChI: InChI=1S/C9H12N2O5S/c12-3-4-6(13)7(14)8(16-4)11-2-1-5(17)10-9(11)15/h1-2,4,6-8,12-14H,3H2,(H,10,15,17)/t4-,6-,7-,8-/m1/s1
Synonyms: Uridine, 4-thio-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-2-one; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-4-thioxo-pyrimidin-2-one; 1-beta-D-ribofuranosyl-4-thiouracil; 1-(β-D-Ribofuranosyl)-4-thioxo-3,4-dihydro-2(1H)-pyrimidinone; 4-Thio Uridine
Nebularine
Description: Nebularine is originally isolated from Agaricus nebularis. Shown to have inhibitory effects against mouse Sarcoma 180 and mycobacteria.
CAT: BRP-01802
CAS: 550-33-4
MF: C10H12N4O4
MF: 252.23
Purity: ≥ 95% by HPLC
Appearance: Off-white to Beige Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 1 g | $799 | In stock |
Storage: Store at -20°C
Density: 1.91±0.1 g/cm3
Melting Point: 180-181°C
Boiling Point: 591.6±60.0 °C at 760 mmHg
InChIKey: MRWXACSTFXYYMV-FDDDBJFASA-N
Solubility: Soluble in DMSO (Slightly), Ethanol, Methanol (Slightly)
CanonicalSMILES: C1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O
IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-purin-9-yloxolane-3,4-diol
InChI: InChI=1S/C10H12N4O4/c15-2-6-7(16)8(17)10(18-6)14-4-13-5-1-11-3-12-9(5)14/h1,3-4,6-8,10,15-17H,2H2/t6-,7-,8-,10-/m1/s1
Synonyms: 9-(beta-D-Ribofuranosyl)-9H-purine; Purine riboside; Purine-9-β-D-ribofuranoside; 9-β-D-Ribofuranosyl-9H-purine; Ribosyl-isopurine; N-D-Ribosylpurine; Purinosine; NSC 65423; 6-Deaminoadenosine; 9-β-D-Ribofuranosylpurine; 9-β-D-Ribosyl-9H-purine; Desaminoadenosine; Isopurine, ribosyl-; Ribosylpurine
N1-EthylpseudoUridine
Description: N1-EthylpseudoUridine is an indispensable compound in the biomedical field, demonstrating profound applications encompass disease research, prevention and intervention. This exceptional substance exhibits unparalleled potential in studying viral onslaughts, malignant neoplasms and neurologic afflictions.
CAT: BRP-01804
CAS: 1613529-72-8
MF: C11H16N2O6
MF: 272.25
Purity: ≥95%
Appearance: White to off-white solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $298 | In stock |
Storage: Storage at 2-8°C
Density: 1.501±0.06 g/cm3
InChIKey: AMMRPAYSYYGRKP-BGZDPUMWSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly), Water (Slightly)
CanonicalSMILES: CCN1C=C(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1-ethylpyrimidine-2,4(1H,3H)-dione
InChI: InChI=1S/C11H16N2O6/c1-2-13-3-5(10(17)12-11(13)18)9-8(16)7(15)6(4-14)19-9/h3,6-9,14-16H,2,4H2,1H3,(H,12,17,18)/t6-,7-,8-,9+/m1/s1
Synonyms: 1-Ethylpseudouridine; 1-ethyl-pseudouridine; 2,4(1H,3H)-Pyrimidinedione, 1-ethyl-5-β-D-ribofuranosyl-; 1-Ethyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione
8-Iodo-guanosine
Description: 8-Iodo-guanosine, a chemical compound used in biomedical research, has proven instrumental in studying the impacts of purine nucleoside analogs on cancers and viral infections. As an iodine-substituted guanosine derivative, it exhibits the potential to act as an inhibitor of RNA viruses like HIV and hepatitis C.
CAT: BRP-01848
CAS: 18438-99-8
MF: C10H12IN5O5
MF: 409.14
Purity: ≥97% by HPLC
Appearance: Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 1 g | $699 | In stock |
Density: 2.85±0.1 g/cm3 (Predicted)
InChIKey: PBEHMRJESXYIKX-UMMCILCDSA-N
CanonicalSMILES: C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)N=C2I)O)O)O
IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-iodo-1H-purin-6-one
InChI: InChI=1S/C10H12IN5O5/c11-9-13-3-6(14-10(12)15-7(3)20)16(9)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H3,12,14,15,20)/t2-,4-,5-,8-/m1/s1
Synonyms: 8-Iodoguanosine; 8-I-rG; 2-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-8-iodo-1H-purin-6(9H)-one; 8-Iodocoumarin; NSC 79218
2'-Deoxy-2'-fluoro-5-iodouridine
Description: It is an antiviral drug and nucleoside analogue with anti-hepatitis B activity.
CAT: BRP-01855
CAS: 55612-21-0
MF: C9H10FIN2O5
MF: 372.09
Purity: ≥95%
Appearance: White to Off-white Powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $358 | In stock |
Storage: Store at 2-8°C
Density: 2.18±0.1 g/cm3 (Predicted)
Melting Point: 216-218°C
InChIKey: IPVFGAYTKQKGBM-UAKXSSHOSA-N
CanonicalSMILES: C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I
IUPAC Name: 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione
InChI: InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5-,6-,8-/m1/s1
Synonyms: 1-(2'-Deoxy-2'-fluoro-beta-D-ribofuranosyl)-5-iodouracil; 2'-epi-Fialuridine; FIRU; 5-Iodo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracil; 1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione
N6-(2-Hydroxyethyl)adenosine
Description: It is an anticonvulsant by activating the adenosine A1 receptor (AA1R).
CAT: BRP-01863
CAS: 4338-48-1
MF: C12H17N5O5
MF: 311.29
Purity: ≥95%
Appearance: White to Off-white Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 5 g | $699 | In stock |
Storage: Store at -20°C
Density: 1.88±0.1 g/cm3
Melting Point: 194-195°C
Boiling Point: 725.8±70.0°C at 760 mmHg
InChIKey: BBOCDRLDMQHWJP-WOUKDFQISA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NCCO
IUPAC Name: (2R,3R,4S,5R)-2-[6-(2-hydroxyethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C12H17N5O5/c18-2-1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(21)8(20)6(3-19)22-12/h4-6,8-9,12,18-21H,1-3H2,(H,13,14,15)/t6-,8-,9-,12-/m1/s1
Synonyms: (2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; N-(2-Hydroxyethyl)adenosine; Adenosine, N-(2-hydroxyethyl)-; N-hydroxyethyl adenosine; 6-(2-Hydroxyethyl)amino-9-beta-D-ribofuranosylpurine; NSC 54251; 6-[(2-Hydroxyethyl)amino]-9-β-D-ribofuranosylpurine; 6-Hydroxyethyladenosine
EIDD-2801
Description: EIDD-2801, derived from N4-hydroxycytidine, is an oral bioavailable broad-spectrum antiviral compound that is effective against SARS-CoV2 infection.
CAT: BRP-01870
CAS: 2492423-29-5
MF: C13H19N3O7
MF: 329.31
Purity: 95%
Appearance: White to off-white solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $386 | In stock |
Storage: Store at 2-8 °C, sealed storage, away from moisture
Density: 1.62±0.1 g/cm3
Melting Point: 156-159 °C
Application: Antiviral Agents
InChIKey: HTNPEHXGEKVIHG-QCNRFFRDSA-N
Solubility: Soluble in DMSO
CanonicalSMILES: CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O
IUPAC Name: [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
InChI: InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1
Synonyms: Molnupiravir; EIDD 2801; EIDD2801; MK-4482; WHO 11853; N4-Hydroxycytidine, 5'-isopropyl ester; beta-D-N4 Hydroxycytidine-5'-isopropyl ester; Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-; EIDD 1931-isopropyl ester; Lagevrio; MK-4482; β-D-N4 hydroxycytidine-5'-isopropyl ester
Related CAS: 2349386-89-4 (Deleted CAS)
Clevudine
Description: Clevudine is an inhibitor of hepatitis B virus (HBV). It is metabolized in cells by the cellular thymidine kinase as well as deoxycytidine kinase to its monophosphate, and subsequently to the di- and triphosphate, which are biologically active.
CAT: BRP-01918
CAS: 163252-36-6
MF: C10H13FN2O5
MF: 260.22
Purity: ≥98% by HPLC
Appearance: White Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 1 g | $568 | In stock |
Storage: Store at -20°C
Density: 1.55±0.1 g/cm3
Melting Point: 184-185 °C
Application: Antiviral Agents
InChIKey: GBBJCSTXCAQSSJ-XQXXSGGOSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
IUPAC Name: 1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
InChI: InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m0/s1
Synonyms: 1-(2'-Deoxy-2'-fluoro-β-L-arabinofuranosyl)-5-methyluracil; L-FMAU; 1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; L FMAU; LFMAU; Levovir; 2'-Fluoro-5-methyl-b-L-arabinofuranosyluracil
Azvudine
Description: Azvudine is a nucleoside reverse transcriptase inhibitor (NRTI), which exhibits inhibtory effects on HIV, HBV and HCV.
CAT: BRP-01974
CAS: 1011529-10-4
MF: C9H11FN6O4
MF: 286.22
Purity: ≥95%
Appearance: Off-white Crystalline Powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $498 | In stock |
Storage: Store at -20°C
Melting Point: 99.0-100.0°C
InChIKey: KTOLOIKYVCHRJW-XZMZPDFPSA-N
Solubility: Soluble in DMSO (10 mM)
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)F
IUPAC Name: 4-amino-1-[(2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C9H11FN6O4/c10-5-6(18)9(3-17,14-15-12)20-7(5)16-2-1-4(11)13-8(16)19/h1-2,5-7,17-18H,3H2,(H2,11,13,19)/t5-,6-,7+,9+/m0/s1
Synonyms: 4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinocytidine; 4'-Azido-2'-deoxy-2'-fluoroaracytidine; RO-0622; 4-amino-1-((2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 2'-deoxy-2'-β-fluoro-4'-azidocytidine; 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)cytosine
(2'R)-2'-deoxy-2'-fluoro-2'-C-methyluridine
Description: PSI-6206 is a selective HCV RNA polymerase inhibitor. It is the unphosphorylated parent compound of triphosphate analog PSI-7409, which is a potent inhibitor of the HCV NS5B RNA dependent RNA polymerase.
CAT: BRP-02007
CAS: 863329-66-2
MF: C10H13FN2O5
MF: 260.22
Purity: ≥95%
Appearance: White to Light Beige Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 5 g | $199 | In stock |
Storage: Store at -20°C
Density: 1.55±0.1 g/cm3
Melting Point: 237.3-238.0 °C
InChIKey: ARKKGZQTGXJVKW-VPCXQMTMSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated)
CanonicalSMILES: CC1(C(C(OC1N2C=CC(=O)NC2=O)CO)O)F
IUPAC Name: 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C10H13FN2O5/c1-10(11)7(16)5(4-14)18-8(10)13-3-2-6(15)12-9(13)17/h2-3,5,7-8,14,16H,4H2,1H3,(H,12,15,17)/t5-,7-,8-,10-/m1/s1
Synonyms: RO-2433; RO 2433; RO2433; PSI6206; PSI 6206; PSI-6206; GS331007; GS-331007; GS 331007; 2'-Deoxy-2'-fluoro-2'-C-methyluridine; Sofosbuvir Metabolite GS331007; 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine; ZL-01 metabolite M9; 2'-Deoxy-2'-Fluoro-2'-methyluridine
PSI-6130
Description: PSI-6130 is a potent and selective inhibitor of HCV NS5B polymerase. It is metabolized to two pharmacologically active species in primary human hepatocytes.
CAT: BRP-02008
CAS: 817204-33-4
MF: C10H14FN3O4
MF: 259.23
Purity: ≥97% by HPLC
Appearance: White to Light Brown Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at -20°C under inert atmosphere
Density: 1.67±0.1 g/cm3 (Predicted)
Melting Point: >162°C (dec.)
Boiling Point: 482.4±55.0 °C at 760 mmHg
Flash Point: 245.5±31.5 °C
InChIKey: NYPIRLYMDJMKGW-VPCXQMTMSA-N
Solubility: Soluble in Methanol (Slightly), Water (Slightly)
CanonicalSMILES: CC1(C(C(OC1N2C=CC(=NC2=O)N)CO)O)F
IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C10H14FN3O4/c1-10(11)7(16)5(4-15)18-8(10)14-3-2-6(12)13-9(14)17/h2-3,5,7-8,15-16H,4H2,1H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1
Synonyms: 2'-Deoxy-2'-fluoro-2'-methylcytidine; R 1656; R-1656; R1656; 2'-F-2'-Me-dC; 2'-Deoxy-2'-fluoro-2'-C-methylcytidine; PSI 6130; PSI6130; 4-Amino-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-2-methyl-β-D-ribofuranosyl)-; 2'-Fluoro-2'-deoxy-2'-methylcytidine
9-(2-Deoxy-2-fluoro-beta-d-arabinofuranosyl)adenine
Description: As an analog of the antitumour and antiviral naturally occurring nucleoside 9-(β-D-arabinofuranosyl)adenine (ara-A), 9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine inhibited the growth of T. vaginalis with an IC50 of 0.09μM.
CAT: BRP-02024
CAS: 20227-41-2
MF: C26H30N2O5
MF: 450.5
Purity: ≥97% by HPLC
Appearance: Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 200 mg | $298 | In stock | |
| 500 mg | $629 | In stock | |
| 1 g | $998 | In stock |
Storage: 4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Density: 2.01±0.1 g/cm3
Melting Point: 233-234 °C
Boiling Point: 628.6±65.0 °C at 760 mmHg
Application: Anti-neoplastic; Inhibits the growth of T. vaginalis with an IC50 of 0.09μM
InChIKey: ZGYYPTJWJBEXBC-GQTRHBFLSA-N
Solubility: Soluble in DMSO, not in water.
CanonicalSMILES: CC1=C(C(=O)OC2=C1C=CC(=C2)OCC(CN3CCC(CC3)C(=O)N)O)CC4=CC=CC=C4
IUPAC Name: (2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
InChI: InChI=1S/C10H12FN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5+,7-,10-/m1/s1
Synonyms: 20227-41-2;9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)adenine;(2R,3R,4S,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol;arabino-F-Ado;CHEMBL2032002;(2R,3R,4S,5R)-5-(6-AMINOPURIN-9-YL)-4-FLUORO-2-(HYDROXYMETHYL)OXOLAN-3-OL;(2R,3R,4S,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol;C10H12FN5O3;SCHEMBL1389499;123334-75-8;BDBM50452569;MFCD12911815;2??-Deoxy-2??-fluoroarabinoadenosine;AKOS027327937;AC-32315;AS-68707;F13969;A855629;2 inverted exclamation mark -Deoxy-2 inverted exclamation mark -fluoroarabinoadenosine;(2R,3R,4S,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol;9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine;
2'-Deoxy-2'-fluoro-beta-D-arabinoguanosine
Description: It is the impurity C of Clofarabine and is also an anticancer agent.
CAT: BRP-02027
CAS: 103884-98-6
MF: C10H12FN5O4
MF: 285.23
Purity: ≥95%
Appearance: White to Off-white Powder to Crystals
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 250 mg | $519 | In stock |
Storage: Store at -20°C
Density: 2.17±0.1 g/cm3 (Predicted)
Melting Point: 275-279°C
Boiling Point: 726.1±70.0°C (Predicted)
InChIKey: UXUZARPLRQRNNX-AYQXTPAHSA-N
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(NC2=O)N
IUPAC Name: 2-amino-9-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C10H12FN5O4/c11-4-6(18)3(1-17)20-9(4)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1H2,(H3,12,14,15,19)/t3-,4+,6-,9-/m1/s1
Synonyms: 9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)guanine; 2'-Deoxy-2'-fluoro-beta-D-arabinoguanosine; 2'-deoxy-2'-fluoro-arabino-guanosine; 2'-FANA-Gr; 2-Amino-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-1H-purin-6(9H)-one; 2-Amino-9-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; 2-Amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-1,9-dihydro-6H-purin-6-one; 2'-Fluoro-Arabinoguanosine; NUK-2
Fiacitabine
Description: Fiacitabine is a selective inhibitior of DNA replication of herpes simplex virus(HSV). It was active at much lower concentrations than arabinosylcytosine, iododeoxyuridine, and arabinosyladenine. It was slightly more active against herpes simplex virus type 1 than acycloquanosine and slightly more toxic to normal cells.
CAT: BRP-02033
CAS: 69123-90-6
MF: C9H11FIN3O4
MF: 371.10
Purity: ≥95%
Appearance: White to off-white solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 10 mg | $298 | In stock | |
| 25 mg | $419 | In stock |
Storage: Store at -20 °C
Density: 2.44±0.1 g/cm3 (Predicted)
Boiling Point: 524.6±60.0 °C at 760 mmHg
Flash Point: 271.1±32.9 °C
Application: Antineoplastic Agents
InChIKey: GIMSJJHKKXRFGV-BYPJNBLXSA-N
Solubility: Soluble in DMSO
CanonicalSMILES: C1=C(C(=NC(=O)N1C2C(C(C(O2)CO)O)F)N)I
IUPAC Name: 4-amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one
InChI: InChI=1S/C9H11FIN3O4/c10-5-6(16)4(2-15)18-8(5)14-1-3(11)7(12)13-9(14)17/h1,4-6,8,15-16H,2H2,(H2,12,13,17)/t4-,5+,6-,8-/m1/s1
Synonyms: 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine; 5-Iodo-2'-deoxy-2'-fluoro-beta-D-arabinocytidine; FICA; DRG-0077; DRG 0077; DRG0077; FOAC; Fluoroiodoaracytidine; Fluorviodoaracytidine; 4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one; 1-β-D-2'-Fluoroarabino-5-iodocytosine; 2'-Fluoro-5-iodo-1-β-D-arabinofuranosylcytosine; NSC 382097
Related CAS: 69124-05-6 (monohydrochloride salt)
3'-Deoxy-3'-fluorouridine
Description: 3'-Deoxy-3'-fluorouridine, a compound of utmost significance in the biomedical industry, assumes a pivotal position in the advancement of antiviral pharmaceuticals targeting RNA virus-associated ailments. This exceptional product showcases its robust antiviral efficacy against a multitude of viruses. Through the powerful mechanism of inhibiting viral replication, 3'-Deoxy-3'-fluorouridine emerges as a propitious contender in the ongoing battle against these formidable infectious maladies.
CAT: BRP-02035
CAS: 57944-13-5
MF: C9H11FN2O5
MF: 246.19
Purity: ≥95%
Appearance: Off-white Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $199 | In stock |
Storage: Store at -20 °C
Density: 1.63±0.1 g/cm3 (Predicted)
InChIKey: FVBOTRDLABQYMI-XVFCMESISA-N
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)F)O
IUPAC Name: 1-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11FN2O5/c10-6-4(3-13)17-8(7(6)15)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1
Synonyms: 3'-Fluoro-3'-deoxyuridine; 1-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)uracil; 1-((2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
N2-iso-Butyroyl-5'-O-(4,4'-dimethoxytrityl)-3'-deoxy-3'-fluoroguanosine
Description: N2-iso-Butyroyl-5'-O-(4,4'-dimethoxytrityl)-3'-deoxy-3'-fluoroguanosine, a biomedical compound, demonstrates its effectiveness in targeting and treating specific diseases. Its therapeutic potential and precise mechanism of action can be explored through the referenced websites, providing comprehensive information concerning drug interactions and its efficacy in addressing various medical conditions.
CAT: BRP-02037
CAS: 2080404-19-7
MF: C35H36FN5O7
MF: 657.69
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 10 mg | $699 | In stock |
Density: 1.38±0.1 g/cm3
InChIKey: DHDSAIMYCCHNMS-UNVYQVKTSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)F)O
IUPAC Name: N-[9-[(2R,3S,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-fluoro-3-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C35H36FN5O7/c1-20(2)31(43)39-34-38-30-28(32(44)40-34)37-19-41(30)33-29(42)27(36)26(48-33)18-47-35(21-8-6-5-7-9-21,22-10-14-24(45-3)15-11-22)23-12-16-25(46-4)17-13-23/h5-17,19-20,26-27,29,33,42H,18H2,1-4H3,(H2,38,39,40,43,44)/t26-,27-,29-,33-/m1/s1
Synonyms: 5'-O-DMT-N2-isobutyryl-3'-Fluoro-3'-deoxyguanosine; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-3'-deoxy-3'-fluoro-N-isobutyrylguanosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy-3'-fluoro-N-(2-methyl-1-oxopropyl)guanosine; N-(9-((2R,3S,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide; 5'-O-DMT-N2-ibu-3'-F-3'-dG; 5'-O-DMT-3'-F-dG(iBu)
